Bronquiolite

McCulloh R, Koster M, Ralston S, et al. Use of intermittent vs continuous pulse oximetry for nonhypoxemic infants and young children hospitalized for bronchiolitis: a randomized clinical trial. JAMA Pediatr. 2015 Oct;169(10):898-904.Texto completo  Resumo

Cunningham S, Rodriguez A, Adams T, et al. Oxygen saturation targets in infants with bronchiolitis (BIDS): a double-blind, randomised, equivalence trial. Lancet. 2015 Sep 12;386(9998):1041-8.Texto completo  Resumo

Lin J, Zhang Y, Xiong L, et al. High-flow nasal cannula therapy for children with bronchiolitis: a systematic review and meta-analysis. Arch Dis Child. 2019 Jun;104(6):564-76. Resumo

Farley R, Spurling GK, Eriksson L, et al. Antibiotics for bronchiolitis in children under two years of age. Cochrane Database Syst Rev. 2014 Oct 9;(10):CD005189.Texto completo  Resumo

Zhang L, Mendoza-Sassi RA, Wainwright C, et al. Nebulised hypertonic saline solution for acute bronchiolitis in infants. Cochrane Database Syst Rev. 2017 Dec 21;(12):CD006458.Texto completo  Resumo

Liet JM, Ducruet T, Gupta V, et al. Heliox inhalation therapy for bronchiolitis in infants. Cochrane Database Syst Rev. 2015 Sep 18;(9):CD006915.Texto completo  Resumo

1. Willwerth BM, Harper MB, Greenes DS. Identifying hospitalized infants who have bronchiolitis and are at high risk for apnea. Ann Emerg Med. 2006 Oct;48(4):441-7. Resumo

2. Schroeder AR, Mansbach JM, Stevenson M, et al. Apnea in children hospitalized with bronchiolitis. Pediatrics. 2013 Nov;132(5):e1194-201. Resumo

3. Hall CB, Weinberg GA, Blumkin AK, et al. Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age. Pediatrics. 2013;132:e341-8. Resumo

4. Fujiogi M, Goto T, Yasunaga H, et al. Trends in bronchiolitis hospitalizations in the United States: 2000-2016. Pediatrics. 2019 Dec;144(6):e20192614.Texto completo  Resumo

5. Thomas E, Mattila JM, Lehtinen P, et al. Burden of respiratory syncytial virus infection during the first year of life. J Infect Dis. 2021 Mar 3;223(5):811-7.Texto completo  Resumo

6. Shi T, McAllister DA, O'Brien KL, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet. 2017 Sep 2;390(10098):946-58.Texto completo  Resumo

7. Obando-Pacheco P, Justicia-Grande AJ, Rivero-Calle I, et al. Respiratory syncytial virus seasonality: a global overview. J Infect Dis. 2018 Apr 11;217(9):1356-64.Texto completo  Resumo

8. Mansbach JM, Camargo CA Jr. Respiratory viruses in bronchiolitis and their link to recurrent wheezing and asthma. Clin Lab Med. 2009 Dec;29(4):741-55. Resumo

9. Jackson DJ, Gangnon RE, Evans MD, et al. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med. 2008;178:667-72.Texto completo  Resumo

10. Lukkarinen M, Koistinen A, Turunen R, et al. Rhinovirus-induced first wheezing episode predicts atopic but not nonatopic asthma at school age. J Allergy Clin Immunol. 2017 Oct;140(4):988-95. Resumo

11. Törmänen S, Lauhkonen E, Riikonen R, et al. Risk factors for asthma after infant bronchiolitis. Allergy. 2018 Apr;73(4):916-22. Resumo

12. Midulla F, Nicolai A, Ferrara M, et al. Recurrent wheezing 36 months after bronchiolitis is associated with rhinovirus infections and blood eosinophilia. Acta Paediatr. 2014 Oct;103(10):1094-9. Resumo

13. Brandão HV, Vieira GO, Vieira TO, et al. Acute viral bronchiolitis and risk of asthma in schoolchildren: analysis of a Brazilian newborn cohort. J Pediatr (Rio J). 2017 May - Jun;93(3):223-9.Texto completo  Resumo

14. Kenmoe S, Kengne-Nde C, Ebogo-Belobo JT, et al. Systematic review and meta-analysis of the prevalence of common respiratory viruses in children <2 years with bronchiolitis in the pre-COVID-19 pandemic era. PLoS One. 2020;15(11):e0242302.Texto completo  Resumo

15. Tripp RA. Pathogenesis of respiratory syncytial virus infection. Viral Immunol. 2004;17(2):165-81. Resumo

16. Martinez FD, Morgan WJ, Wright AL, et al. Diminished lung function as a predisposing factor for wheezing respiratory illness in infants. N Engl J Med. 1988 Oct 27;319(17):1112-7. Resumo

17. Turner SW, Young S, Landau LI, et al. Reduced lung function both before bronchiolitis and at 11 years. Arch Dis Child. 2002 Nov;87(5):417-20. Resumo

18. Stevenson MD, Mansbach JM, Mowad E, et al. Prenatal versus postnatal tobacco smoke exposure and intensive care use in children hospitalized with bronchiolitis. Acad Pediatr. 2016 Jul;16(5):446-52.Texto completo  Resumo

19. Lanari M, Vandini S, Adorni F, et al. Prenatal tobacco smoke exposure increases hospitalizations for bronchiolitis in infants. Respir Res. 2015 Dec 22;16:152.Texto completo  Resumo

20. Jones LL, Hashim A, McKeever T, et al. Parental and household smoking and the increased risk of bronchitis, bronchiolitis and other lower respiratory infections in infancy: systematic review and meta-analysis. Respir Res. 2011 Jan 10;12:5.Texto completo  Resumo

21. Carugno M, Dentali F, Mathieu G, et al. PM10 exposure is associated with increased hospitalizations for respiratory syncytial virus bronchiolitis among infants in Lombardy, Italy. Environ Res. 2018 Oct;166:452-7. Resumo

22. Kim CK, Kim SW, Park CS, et al. Bronchoalveolar lavage cytokine profiles in acute asthma and acute bronchiolitis. J Allergy Clin Immunol. 2003 Jul;112(1):64-71. Resumo

23. Oh JW, Lee HB, Yum MK, et al. ECP level in nasopharyngeal secretions and serum from children with respiratory virus infections and asthmatic children. Allergy Asthma Proc. 2000 Mar-Apr;21(2):97-100. Resumo

24. Legg JP, Hussain IR, Warner JA, et al. Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med. 2003 Sep 15;168(6):633-9.Texto completo  Resumo

25. Lukacs NW, Tekkanat KK, Berlin A, et al. Respiratory syncytial virus predisposes mice to augmented allergic airway responses via IL-13-mediated mechanisms. J Immunol. 2001 Jul 15;167(2):1060-5.Texto completo  Resumo

26. Welliver TP, Garofalo RP, Hosakote Y, et al. Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J Infect Dis. 2007 Apr 15;195(8):1126-36. Resumo

27. Copenhaver CC, Gern JE, Li Z, et al. Cytokine response patterns, exposure to viruses, and respiratory infections in the first year of life. Am J Respir Crit Care Med. 2004 Jul 15;170(2):175-80. Resumo

28. Guerra S, Lohman IC, Halonen M, et al. Reduced interferon gamma production and soluble CD14 levels in early life predict recurrent wheezing by 1 year of age. Am J Respir Crit Care Med. 2004 Jan 1;169(1):70-6. Resumo

29. Jozwik A, Habibi MS, Paras A, et al. RSV-specific airway resident memory CD8+ T cells and differential disease severity after experimental human infection. Nat Commun. 2015 Dec 21;6:10224.Texto completo  Resumo

30. Arruvito L, Raiden S, Geffner J. Host response to respiratory syncytial virus infection. Curr Opin Infect Dis. 2015 Jun;28(3):259-66. Resumo

31. Hosakote YM, Jantzi PD, Esham DL, et al. Viral-mediated inhibition of antioxidant enzymes contributes to the pathogenesis of severe respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med. 2011 Jun 1;183(11):1550-60. Resumo

32. Pangesti KNA, El Ghany MA, Kesson AM, et al. Respiratory syncytial virus in the Western Pacific Region: a systematic review and meta-analysis. J Glob Health. 2019 Dec;9(2):020431.Texto completo  Resumo

33. Townsi N, Laing IA, Hall GL, et al. The impact of respiratory viruses on lung health after preterm birth. Eur Clin Respir J. 2018 Aug 1;5(1):1487214.Texto completo  Resumo

34. Friedrich L, Pitrez PM, Stein RT, et al. Growth rate of lung function in healthy preterm infants. Am J Respir Crit Care Med. 2007 Dec 15;176(12):1269-73. Resumo

35. Allen J, Zwerdling R, Ehrenkranz R, et al. Statement on the care of the child with chronic lung disease of infancy and childhood. Am J Respir Crit Care Med. 2003 Aug 1;168(3):356-96.Texto completo  Resumo

36. Rice JL, McGrath-Morrow SA, Collaco JM. Indoor air pollution sources and respiratory symptoms in bronchopulmonary dysplasia. J Pediatr. 2020 Jul;222:85-90.e2.Texto completo  Resumo

37. Fauroux B, Hascoët JM, Jarreau PH, et al. Risk factors for bronchiolitis hospitalization in infants: a French nationwide retrospective cohort study over four consecutive seasons (2009-2013). PLoS One. 2020;15(3):e0229766.Texto completo  Resumo

38. Centers for Disease Control and Prevention. RSV in infants and young children. Dec 2020 [internet publication].Texto completo

39. MacDonald NE, Hall CB, Suffin SC, et al. Respiratory syncytial viral infection in infants with congenital heart disease. N Engl J Med. 1982 Aug 12;307(7):397-400. Resumo

40. Navas L, Wang E, de Carvalho V, et al. Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. Pediatric Investigators Collaborative Network on Infections in Canada. J Pediatr. 1992 Sep;121(3):348-54. Resumo

41. Lehners N, Tabatabai J, Prifert C, et al. Long-term shedding of influenza virus, parainfluenza virus, respiratory syncytial virus and nosocomial epidemiology in patients with hematological disorders. PLoS One. 2016 Feb 11;11(2):e0148258.Texto completo  Resumo

42. Ralston SL, Lieberthal AS, Meissner HC, et al; American Academy of Pediatrics. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics. 2014 Nov;134(5):e1474-502.Texto completo  Resumo

43. Simões EAF, Bont L, Manzoni P, et al. Past, present and future approaches to the prevention and treatment of respiratory syncytial virus infection in children. Infect Dis Ther. 2018 Mar;7(1):87-120.Texto completo  Resumo

44. Committee on Infectious Diseases and Bronchiolitis Guidelines Committee, American Academy of Pediatrics. Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics. 2014 Aug;134(2):415-20. [Reaffirmed: Pediatrics. 2019 Aug;144(2):e20191767.]Texto completo  Resumo

45. Morris SK, Dzolganovski B, Beyene J, et al. A meta-analysis of the effect of antibody therapy for the prevention of severe respiratory syncytial virus infection. BMC Infect Dis. 2009 Jul 5;9:106.Texto completo  Resumo

46. Bollani L, Baraldi E, Chirico G, et al. Revised recommendations concerning palivizumab prophylaxis for respiratory syncytial virus (RSV). Ital J Pediatr. 2015 Dec 15;41:97.Texto completo  Resumo

47. Feltes TF, Cabalka AK, Meissner HC, et al. Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease. J Pediatr. 2003 Oct;143(4):532-40. Resumo

48. Øymar K, Skjerven HO, Mikalsen IB. Acute bronchiolitis in infants, a review. Scand J Trauma Resusc Emerg Med. 2014 Apr 3;22:23.Texto completo  Resumo

49. Zorc JJ, Hall CB. Bronchiolitis: recent evidence on diagnosis and management. Pediatrics. 2010 Feb;125(2):342-9. Resumo

50. Sarmiento L, Rojas-Soto GE, Rodríguez-Martínez CE. Predictors of inappropriate use of diagnostic tests and management of bronchiolitis. Biomed Res Int. 2017;2017:9730696.Texto completo  Resumo

51. Caballero MT, Polack FP, Stein RT. Viral bronchiolitis in young infants: new perspectives for management and treatment. J Pediatr (Rio J). 2017 Nov - Dec;93(suppl 1):75-83.Texto completo  Resumo

52. Cavaye D, Roberts DP, Saravanos GL, et al. Evaluation of national guidelines for bronchiolitis: AGREEments and controversies. J Paediatr Child Health. 2019 Jan;55(1):25-31. Resumo

53. McCulloh R, Koster M, Ralston S, et al. Use of intermittent vs continuous pulse oximetry for nonhypoxemic infants and young children hospitalized for bronchiolitis: a randomized clinical trial. JAMA Pediatr. 2015 Oct;169(10):898-904.Texto completo  Resumo

54. Friedman JN, Rieder MJ, Walton JM; Canadian Paediatric Society, Acute Care Committee, Drug Therapy and Hazardous Substances Committee. Bronchiolitis: recommendations for diagnosis, monitoring and management of children one to 24 months of age. Paediatr Child Health. 2014 Nov;19(9):485-98.Texto completo  Resumo

55. Cunningham S, Rodriguez A, Adams T, et al. Oxygen saturation targets in infants with bronchiolitis (BIDS): a double-blind, randomised, equivalence trial. Lancet. 2015 Sep 12;386(9998):1041-8.Texto completo  Resumo

56. Paediatric Research in Emergency Departments International Collaborative (PREDICT) Network, Australasia. Australasian bronchiolitis guideline. Jul 2021 [internet publication].Texto completo

57. National Institute for Health and Care Excellence. Bronchiolitis in children: diagnosis and management. Aug 2021 [internet publication].Texto completo

58. Chao JH, Lin RC, Marneni S, et al. Predictors of airspace disease on chest x-ray in emergency department patients with clinical bronchiolitis: a systematic review and meta-analysis. Acad Emerg Med. 2016 Oct;23(10):1107-18.Texto completo  Resumo

59. Ecochard-Dugelay E, Beliah M, Perreaux F, et al. Clinical predictors of radiographic abnormalities among infants with bronchiolitis in a paediatric emergency department. BMC Pediatr. 2014 Jun 6;14:143.Texto completo  Resumo

60. Allen JL, Wolfson MR, McDowell K, et al. Thoracoabdominal asynchrony in infants with airflow obstruction. Am Rev Respir Dis. 1990 Feb;141(2):337-42. Resumo

61. Schuh S, Freedman S, Coates A, et al. Effect of oximetry on hospitalization in bronchiolitis: a randomized clinical trial. JAMA. 2014 Aug 20;312(7):712-8. Resumo

62. American Thoracic Society; European Respiratory Society. ATS/ERS statement: raised volume forced expirations in infants: guidelines for current practice. Am J Respir Crit Care Med. 2005 Dec 1;172(11):1463-71.Texto completo  Resumo

63. Palmer J, Allen J, Mayer O. Tidal breathing analysis. NeoReviews. 2004;5:E186-93.Texto completo

64. Lin J, Zhang Y, Xiong L, et al. High-flow nasal cannula therapy for children with bronchiolitis: a systematic review and meta-analysis. Arch Dis Child. 2019 Jun;104(6):564-76. Resumo

65. Moreel L, Proesmans M. High flow nasal cannula as respiratory support in treating infant bronchiolitis: a systematic review. Eur J Pediatr. 2020 May;179(5):711-8. Resumo

66. O'Brien S, Craig S, Babl FE, et al. 'Rational use of high-flow therapy in infants with bronchiolitis. What do the latest trials tell us?' A Paediatric Research in Emergency Departments International Collaborative perspective. J Paediatr Child Health. 2019 Jul;55(7):746-52. Resumo

67. Franklin D, Babl FE, Schlapbach LJ, et al. A randomized trial of high-flow oxygen therapy in infants with bronchiolitis. N Engl J Med. 2018 Mar 22;378(12):1121-31.Texto completo  Resumo

68. Jat KR, Mathew JL. Continuous positive airway pressure (CPAP) for acute bronchiolitis in children. Cochrane Database Syst Rev. 2019 Jan 31;(1):CD010473.Texto completo  Resumo

69. Combret Y, Prieur G, LE Roux P, et al. Non-invasive ventilation improves respiratory distress in children with acute viral bronchiolitis: a systematic review. Minerva Anestesiol. 2017 Jun;83(6):624-37.Texto completo  Resumo

70. Hernandez E, Khoshoo V, Thoppil D, et al. Aspiration: a factor in rapidly deteriorating bronchiolitis in previously healthy infants? Pediatr Pulmonol. 2002 Jan;33(1):30-1. Resumo

71. Oakley E, Borland M, Neutze J, et al. Nasogastric hydration versus intravenous hydration for infants with bronchiolitis: a randomised trial. Lancet Respir Med. 2013 Apr;1(2):113-20. Resumo

72. Valla FV, Baudin F, Demaret P, et al. Nutritional management of young infants presenting with acute bronchiolitis in Belgium, France and Switzerland: survey of current practices and documentary search of national guidelines worldwide. Eur J Pediatr. 2019 Mar;178(3):331-40. Resumo

73. American Academy of Pediatrics. Respiratory syncytial virus. In: Kimberlin DW, Barnett ED, Lynfield R, et al, eds. Red Book (2021). Report of the Committee on Infectious Diseases. 32nd ed. Elk Grove Village, IL: American Academy of Pediatrics; 2021:628-36.Texto completo

74. Fernandes RM, Bialy LM, Vandermeer B, et al. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev. 2013 Jun 4;(6):CD004878.Texto completo  Resumo

75. Alansari K, Sakran M, Davidson BL, et al. Oral dexamethasone for bronchiolitis: a randomized trial. Pediatrics. 2013 Oct;132(4):e810-6. Resumo

76. Shein SL, Rotta AT, Speicher R, et al. Corticosteroid therapy during acute bronchiolitis in patients who later develop asthma. Hosp Pediatr. 2017 Jul;7(7):403-9.Texto completo  Resumo

77. Gadomski AM, Scribani MB. Bronchodilators for bronchiolitis. Cochrane Database Syst Rev. 2014 Jun 17;(6):CD001266.Texto completo  Resumo

78. Ralston S, Hill V, Waters A. Occult serious bacterial infection in infants younger than 60 to 90 days with bronchiolitis: a systematic review. Arch Pediatr Adolesc Med. 2011 Oct;165(10):951-6. Resumo

79. Pinto LA, Pitrez PM, Luisi F, et al. Azithromycin therapy in hospitalized infants with acute bronchiolitis is not associated with better clinical outcomes: a randomized, double-blinded, and placebo-controlled clinical trial. J Pediatr. 2012 Dec;161(6):1104-8. Resumo

80. Farley R, Spurling GK, Eriksson L, et al. Antibiotics for bronchiolitis in children under two years of age. Cochrane Database Syst Rev. 2014 Oct 9;(10):CD005189.Texto completo  Resumo

81. McDaniel CE, Ralston S, Lucas B, et al. Association of diagnostic criteria with urinary tract infection prevalence in bronchiolitis: a systematic review and meta-analysis. JAMA Pediatr. 2019 Mar 1;173(3):269-77.Texto completo  Resumo

82. Zhang L, Mendoza-Sassi RA, Wainwright C, et al. Nebulised hypertonic saline solution for acute bronchiolitis in infants. Cochrane Database Syst Rev. 2017 Dec 21;(12):CD006458.Texto completo  Resumo

83. Brooks CG, Harrison WN, Ralston SL, et al. Association between hypertonic saline and hospital length of stay in acute viral bronchiolitis: a reanalysis of 2 meta-analyses. JAMA Pediatr. 2016 Jun 1;170(6):577-84.Texto completo  Resumo

84. Heikkilä P, Renko M, Korppi M. Hypertonic saline inhalations in bronchiolitis - a cumulative meta-analysis. Pediatr Pulmonol. 2018 Feb;53(2):233-42. Resumo

85. Harrison W, Angoulvant F, House S, et al. Hypertonic saline in bronchiolitis and type I error: a trial sequential analysis. Pediatrics. 2018 Sep;142(3):e20181144.Texto completo  Resumo

86. Enriquez A, Chu IW, Mellis C, et al. Nebulised deoxyribonuclease for viral bronchiolitis in children younger than 24 months. Cochrane Database Syst Rev. 2012 Nov 14;(11):CD008395.Texto completo  Resumo

87. Hartling L, Bialy LM, Vandermeer B, et al. Epinephrine for bronchiolitis. Cochrane Database Syst Rev. 2011 Jun 15;(6):CD003123.Texto completo  Resumo

88. Hartling L, Fernandes RM, Bialy L, et al. Steroids and bronchodilators for acute bronchiolitis in the first two years of life: systematic review and meta-analysis. BMJ. 2011 Apr 6;342:d1714.Texto completo  Resumo

89. Plint AC, Johnson DW, Patel H, et al. Pediatric Emergency Research Canada (PERC). Epinephrine and dexamethasone in children with bronchiolitis. N Engl J Med. 2009 May 14;360(20):2079-89.Texto completo  Resumo

90. Roqué i Figuls M, Giné-Garriga M, Granados Rugeles C, et al. Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old. Cochrane Database Syst Rev. 2016 Feb 1;(2):CD004873.Texto completo  Resumo

91. Gajdos VK, Katsahian S, Beydon N, et al. Effectiveness of chest physiotherapy in infants hospitalized with acute bronchiolitis: a multicenter, randomized, controlled trial. PLoS Med. 2010 Sep 28;7(9):e1000345.Texto completo  Resumo

92. Gomes GR, Donadio MVF. Effects of the use of respiratory physiotherapy in children admitted with acute viral bronchiolitis. Arch Pediatr. 2018 Aug;25(6):394-8. Resumo

93. Luchetti M, Ferrero F, Gallini C, et al. Multicenter, randomized, controlled study of porcine surfactant in severe respiratory syncytial virus-induced respiratory failure. Pediatr Crit Care Med. 2002 Jul;3(3):261-8. Resumo

94. Tibby SM, Hatherill M, Wright SM, et al. Exogenous surfactant supplementation in infants with respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med. 2000 Oct;162(4 Pt 1):1251-6. Resumo

95. Barreira ER, Precioso AR, Bousso A. Pulmonary surfactant in respiratory syncytial virus bronchiolitis: the role in pathogenesis and clinical implications. Pediatr Pulmonol. 2011 May;46(5):415-20. Resumo

96. Jat KR, Chawla D. Surfactant therapy for bronchiolitis in critically ill infants. Cochrane Database Syst Rev. 2015 Aug 24;(8):CD009194.Texto completo  Resumo

97. Martinon-Torres F, Rodriguez-Nunez A, Martinon-Sanchez JM. Heliox therapy in infants with acute bronchiolitis. Pediatrics. 2002 Jan;109(1):68-73. Resumo

98. Liet JM, Ducruet T, Gupta V, et al. Heliox inhalation therapy for bronchiolitis in infants. Cochrane Database Syst Rev. 2015 Sep 18;(9):CD006915.Texto completo  Resumo

99. Kim IK, Phrampus E, Sikes K, et al. Helium-oxygen therapy for infants with bronchiolitis: a randomized controlled trial. Arch Pediatr Adolesc Med. 2011 Dec;165(12):1115-22. Resumo

100. Chowdhury MM, McKenzie SA, Pearson CC, et al. Heliox therapy in bronchiolitis: phase III multicenter double-blind randomized controlled trial. Pediatrics. 2013 Apr;131(4):661-9. Resumo

101. Amirav I, Luder AS, Kruger N, et al. A double-blind, placebo-controlled, randomized trial of montelukast for acute bronchiolitis. Pediatrics. 2008 Dec;122(6):e1249-55. Resumo

102. Kim CK, Choi J, Kim HB, et al. A randomized intervention of montelukast for post-bronchiolitis: effect on eosinophil degranulation. J Pediatr. 2010 May;156(5):749-54. Resumo

103. Bisgaard H, Flores-Nunez A, Goh A, et al. Study of montelukast for the treatment of respiratory symptoms of post-respiratory syncytial virus bronchiolitis in children. Am J Resp Crit Care Med. 2008 Oct 15;178(8):854-60.Texto completo  Resumo

104. Proesmans M, Sauer K, Govaere E, et al. Montelukast does not prevent reactive airway disease in young children hospitalized for RSV bronchiolitis. Acta Paediatr. 2009 Nov;98(11):1830-4. Resumo

105. Zedan M, Gamil N, El-Assmy M, et al. Montelukast as an episodic modifier for acute viral bronchiolitis: a randomized trial. Allergy Asthma Proc. 2010 Mar-Apr;31(2):147-53. Resumo

106. Liu F, Ouyang J, Sharma AN, et al. Leukotriene inhibitors for bronchiolitis in infants and young children. Cochrane Database Syst Rev. 2015 Mar 16;(3):CD010636.Texto completo  Resumo

107. Pérez-Gutiérrez F, Otárola-Escobar I, Arenas D. Are leukotriene inhibitors useful for bronchiolitis? Medwave. 2016 Dec 16;16(suppl 5):e6799. Resumo

108. Alansari K, Toaimah FH, Khalafalla H, et al. Caffeine for the treatment of apnea in bronchiolitis: a randomized trial. J Pediatr. 2016 Oct;177:204-11.e3. Resumo

109. Marchisio P, Consonni D, Baggi E, et al. Vitamin D supplementation reduces the risk of acute otitis media in otitis-prone children. Pediatr Infect Dis J. 2013 Oct;32(10):1055-60.Texto completo  Resumo

110. Forno E, Bacharier LB, Phipatanakul W, et al. Effect of vitamin D3 supplementation on severe asthma exacerbations in children with asthma and low vitamin D levels: the VDKA randomized clinical trial. JAMA. 2020 Aug 25;324(8):752-60.Texto completo  Resumo

111. Zisi D, Challa A, Makis A. The association between vitamin D status and infectious diseases of the respiratory system in infancy and childhood. Hormones (Athens). 2019 Dec;18(4):353-63.Texto completo  Resumo

112. Saad K, Abd Aziz NHR, El-Houfey AA, et al. Trial of vitamin D supplementation in infants with bronchiolitis: a randomized, double-blind, placebo-controlled study. Pediatr Allergy Immunol Pulmonol. 2015;28(2):102-6.Texto completo

113. Mahyar A, Ayazi P, Ahmadi NK, et al. Zinc sulphate for acute bronchiolitis: a double-blind placebo-controlled trial. Infez Med. 2016 Dec 1;24(4):331-6. Resumo

114. Tal A, Greenberg D, Av-Gay Y, et al. Nitric oxide inhalations in bronchiolitis: a pilot, randomized, double-blinded, controlled trial. Pediatr Pulmonol. 2018 Jan;53(1):95-102. Resumo

115. Goldbart A, Golan-Tripto I, Pillar G, et al. Inhaled nitric oxide therapy in acute bronchiolitis: a multicenter randomized clinical trial. Sci Rep. 2020 Jun 15;10(1):9605.Texto completo  Resumo

116. Zhou Y, Bacharier LB, Isaacson-Schmid M, et al. Azithromycin therapy during respiratory syncytial virus bronchiolitis: upper airway microbiome alterations and subsequent recurrent wheeze. J Allergy Clin Immunol. 2016 Oct;138(4):1215-9.Texto completo  Resumo

117. Shang X, Liabsuetrakul T, Sangsupawanich P, et al. Efficacy and safety of Laggera pterodonta in children 3-24 months with acute bronchiolitis: a randomized controlled trial. Clin Respir J. 2017 May;11(3):296-304. Resumo

118. Sigurs N, Gustafsson PM, Bjarnason R, et al. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am J Respir Crit Care Med. 2005 Jan 15;171(2):137-41.Texto completo  Resumo

119. Wu P, Dupont WD, Griffin MR, et al. Evidence of a causal role of winter virus infection during infancy in early childhood asthma. Am J Respir Crit Care Med. 2008 Dec 1;178(11):1123-9. Resumo

120. Thomsen SF, van der Sluis S, Stensballe LG, et al. Exploring the association between severe respiratory syncytial virus infection and asthma: a registry-based twin study. Am J Respir Crit Care Med. 2009 Jun 15;179(12):1091-7. Resumo